27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

ACXP Insider Trading (Acurx Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $74,605.84
Insider Selling (Last 12 Months): $0.00

Acurx Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Acurx Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acurx Pharmaceuticals Share Price & Price History

Current Price: $3.59
Price Change: Price Decrease of -0.04 (-1.10%)
As of 06/30/2022 01:16 PM ET

This chart shows the closing price history over time for ACXP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Acurx Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/23/2021Carl SailerDirectorBuy5,161$4.84$24,979.24View SEC Filing Icon  
11/19/2021David P. LuciCEOBuy5,200$4.80$24,960.00View SEC Filing Icon  
11/19/2021Robert J. DeLucciaDirectorBuy5,034$4.90$24,666.60View SEC Filing Icon  
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Acurx Pharmaceuticals (NASDAQ:ACXP)

0.72% of Acurx Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACXP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Acurx Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/12/2022BlackRock Inc.16,699$55K0.0%+149.8%0.163%Search for SEC Filing on Google Icon
1/10/2022Patriot Financial Group Insurance Agency LLC7,000$30K0.0%+75.0%0.069%Search for SEC Filing on Google Icon
11/15/2021Tocqueville Asset Management L.P.19,100$98K0.0%+91.0%0.189%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.6,515$33K0.0%N/A0.064%Search for SEC Filing on Google Icon
8/16/2021Tocqueville Asset Management L.P.10,000$64K0.0%N/A0.105%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Acurx Pharmaceuticals logo
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Read More on Acurx Pharmaceuticals

Today's Range

Now: $3.59
Low: $3.55
High: $3.75

50 Day Range

MA: $3.27
Low: $2.42
High: $4.00

52 Week Range

Now: $3.59
Low: $2.33
High: $6.84

Volume

1,261 shs

Average Volume

22,916 shs

Market Capitalization

$36.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Acurx Pharmaceuticals?

Acurx Pharmaceuticals' top insider investors include:
  1. Carl Sailer (Director)
  2. David P Luci (CEO)
  3. Robert J Deluccia (Director)
Learn More about top insider investors at Acurx Pharmaceuticals.
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.